Results 41 to 50 of about 148,737 (346)

Retrospective analysis of infections prevalence in patients with progressive systemic sclerosis treated with cyclophosphamide

Journal of Medical Science, 2015
Aim. Assessment of infections prevalence rate, type and severity in patients diagnosed with progressive systemic sclerosis (PSS), treated with cyclophosphamide (CTX), during 12 months of observations. Material and methods.
Małgorzata Schlabs, Katarzyna Pawlak-Buś, Piotr Leszczyński   +2 more
doaj   +1 more source

Treatment of Systemic Sclerosis Associated Interstitial Lung Disease

Journal of Clinical Rheumatology and Immunology, 2020
Systemic sclerosis (SSc) is a systemic connective tissue disorder characterized by progressive skin and visceral organ fibrosis, vasculopathy, and immune dysregulation.
Iris Yan Ki Tang, So Ho
doaj   +1 more source

Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis – case report and literature review

Rheumatology, 2017
Diabetic sclerodactyly is a frequently recognized skin finding that may occur in patients with diabetes mellitus but coexistence of diabetes and systemic sclerosis is rare.
Ewa Wielosz, Maria Kurowska, Dorota Suszek, Maria Majdan   +3 more
doaj   +1 more source

Determinants of Depressive Symptoms, Quality of Life, Subjective Health Status and Physical Limitation in Patients with Systemic Sclerosis

Acta Dermato-Venereologica, 2023
Systemic sclerosis is a progressive connective tissue disease for which there is limited knowledge about physical limitations, quality of life and depression.
Stefanie Heyne, Eva Haufe, Stefan Beissert, Jochen Schmitt, Claudia Günther   +4 more
doaj   +1 more source

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner, Petra Nytrova, Jan Krasensky, Eliza Varju, Miguel D'haeseleer, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova, Niels Bergsland   +12 more
wiley   +1 more source

Selected methods of rehabilitation in systemic sclerosis

Przegląd Dermatologiczny, 2017
Systemic sclerosis is a chronic connective tissue disease characterized by microvascular abnormalities, immune disturbances and progressive fibrosis of the skin and internal organs.
Agnieszka Gerkowicz, Angelika Bielecka, Justyna Buś, Beata Polkowska-Pruszyńska, Dorota Krasowska   +4 more
doaj   +1 more source

Systemic sclerosis and tachycardia–bradycardia syndrome: a case report

Journal of Medical Case Reports, 2022
Background Systemic sclerosis is a multisystemic character autoimmune disease. It is characterized by vascular dysfunction and progressive fibrosis affecting mainly the skin but also different internal organs.
Raid Faraj, Nabil Laktib, Safae Hilal, Fadoun Hassan, Amine Krimech, Alaa Bouanani, Mohamed Sarsari, Ibtissam Fellat, Jamila Zarzur, Mohamed Cherti   +9 more
doaj   +1 more source

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad, Taimoon Rasheed, Momina Riaz Siddiqui, Hamza Hamid, Marwah Bintay Khalid, Haroon Shabbir, Besher Shami, Abdullah, Syed Ijlal Ahmed   +8 more
wiley   +1 more source

Unusual case of pulmonary renal syndrome with autopsy findings

Indian Journal of Pathology and Microbiology, 2013
Scleroderma renal crises (SRC) is a serious complication of systemic sclerosis whose prognosis remains serious despite management with angiotensin-converting enzyme inhibitors, antihypertensives and dialysis. Pulmonary renal syndrome (PRS), characterised
Sonia Badwal, Jyoti Kotwal, Prem Prakash Varma   +2 more
doaj   +1 more source

Management of systemic sclerosis: the first five years.

Current Opinion in Rheumatology, 2020
PURPOSE OF REVIEW This review provides a risk-stratified and evidence-based management for subsets of systemic sclerosis (SSc) patients in the first five years from disease onset.
D. Roofeh, D. Khanna
semanticscholar   +1 more source